Baudax Bio Total Current Liabilities

Baudax Bio (BXRX) currently reports a total current liabilities of $19M as of September 2023. That compares with $21M in the prior-year period — down 10.5% year over year. Use the charts on this page to explore Baudax Bio's total current liabilities history and peer comparisons.

Baudax Bio's total current liabilities decreased from $21M to $19M — a 10.5% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Baudax Bio reported $19M in total current liabilities as of September 2023. That compares with $21M in the prior-year period — down 10.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Baudax Bio, and consider following BXRX for alerts when major investors trade the stock.

Baudax Bio is classified in the Healthcare sector. On total current liabilities, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BXRX with unrelated industries.